Heartflow, Inc. (NASDAQ:HTFL) Given Average Rating of “Moderate Buy” by Analysts

Heartflow, Inc. (NASDAQ:HTFL) has been assigned an average rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $38.50.

A number of research firms recently weighed in on HTFL. JPMorgan Chase & Co. boosted their target price on Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Wells Fargo & Company initiated coverage on shares of Heartflow in a research note on Wednesday. They issued an “overweight” rating and a $38.00 price objective for the company. Stifel Nicolaus boosted their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Canaccord Genuity Group lifted their price objective on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th.

Insiders Place Their Bets

In other Heartflow news, Director Jeffrey C. Lightcap bought 40,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was bought at an average price of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the acquisition, the director directly owned 40,000 shares in the company, valued at $1,053,600. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Institutional Trading of Heartflow

A number of hedge funds and other institutional investors have recently modified their holdings of HTFL. Wellington Management Group LLP purchased a new position in Heartflow during the 3rd quarter valued at about $164,263,000. Baillie Gifford & Co. purchased a new position in shares of Heartflow during the third quarter valued at approximately $101,182,000. Schusterman Interests LLC bought a new stake in shares of Heartflow in the 3rd quarter worth approximately $65,274,000. Vanguard Group Inc. bought a new position in Heartflow during the 3rd quarter valued at approximately $48,871,000. Finally, Capital International Investors purchased a new position in Heartflow during the third quarter valued at $43,671,000.

Heartflow Trading Down 0.9%

Shares of NASDAQ:HTFL opened at $30.82 on Friday. Heartflow has a 12 month low of $25.38 and a 12 month high of $41.22. The stock has a market capitalization of $2.62 billion and a PE ratio of -17.03. The company’s 50 day moving average price is $30.73.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.